State Agencies | Online Services
 

Neonatal Abstinence Syndrome (NAS) Hospital Reporting in Ohio

As of July 10, 2014, Ohio Revised Code 3711.30 requires maternity units, newborn care nurseries, and maternity homes to report to the Ohio Department of Health (ODH) the number of newborns born to Ohio residents who are diagnosed as opioid dependent at birth commonly referred to as “NAS.”  

In order to assist hospitals in complying with this law, ODH will be partnering with the Ohio Hospital Association to access hospital discharge data associated with NAS.

As a result, Ohio hospitals that report their discharge data to OHA need not do anything different in order to comply with R.C. 3711.30 (130 GA HB 315)ODH will obtain the required data from OHA’s discharge dataset. 

ODH is unable to confirm whether your facility reports discharge data to OHA. 

If your facility does not currently report data to OHA, please contact ODH at HealthyOhio@odh.ohio.gov for further instructions.  

ODH shall produce a summary report once OHA data are available after the end of the calendar year.  The summary will be available to the public.

NAS Data and Related Resources:

Current Efforts to Address NAS in Ohio:

Recommendations to Prevent NAS:

  • All newborns and at-risk breastfeeding children should be screened for NAS symptoms. Standardized instruments like the Neonatal Abstinence Scoring System1 should be used to evaluate these groups for NAS. Researchers should develop new instruments for other drug classes if none exist.
  • All physicians and nurses who treat women should be educated about the signs of addiction and utilize brief screening tools for at-risk women. Women seeking prenatal care should be screened for substance use and counseled on the impact of such use on their babies. According to the Pregnancy Risk Assessment Monitoring System2,  55 percent of mothers reported discussing alcohol, prescription medication, over- the-counter medication and illegal drug use with the healthcare provider during a prenatal visit.
  • Women of childbearing age being treated for substance abuse or dependence should be counseled on the impact of substance use on pregnancy. Women who screen positive for drug abuse and dependence should also be screened for Hepatitis C and HIV because of the high comorbidity.
  • Prescribers should carefully consider whether opioid analgesics should be used on a long-term basis during pregnancy.
  • Women who deliver drug-addicted babies should be provided with aftercare services, so the mothers can cope with their addiction and learn about the special needs of their infants.
  • Alcohol and drug abuse prevention activities should be targeted to women of prime child-bearing age.
  • Promising practices in the diagnosis and treatment of NAS should be identified and promoted throughout the state.

References:

  1. Finnegan, L.P. (1990). Neonatal abstinence syndrome: Assessment and pharmacotherapy. In N. Nelson (Ed.), Current therapy in neonatal-perinatal medicine (2nd ed.). Ontario: BC Decker.
  2. Ohio Pregnancy Risk Assessment Monitoring System, Division of Family and Community Health Services, Ohio Department of Health. 2012.


 

  

Page updated 03/9/2017